Literature DB >> 3983055

The clinical response to treatment in adult Cushing's syndrome following remission of hypercortisolaemia.

E J Ross, D C Linch.   

Abstract

The clinical response of 57 adult patients with Cushing's syndrome due to bilateral adrenocortical hyperplasia or adrenocortical adenoma is documented following resolution of hypercortisolaemia by various forms of treatment. Despite satisfactory biochemical remission of the disease the clinical result was far less satisfactory when assessed by persistence of obesity (55%), menstrual irregularity (41%), hypertension (29%) and insulin-dependent diabetes (22%). Myopathy, hirsuitism and psychological abnormalities persisted to a lesser extent. The mortality rate of the series over a 30 year follow-up period was 4 times that of a general population matched for sex, age and year of entry into the series. Cardiovascular disease was the cause of death in 85%. Irreparable cardiovascular disease is produced early in the course of hypercortisolaemia, emphasizing the vital importance of the earliest possible recognition and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3983055      PMCID: PMC2418188          DOI: 10.1136/pgmj.61.713.205

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

1.  Results of treatment in 108 patients with Cushing's syndrome.

Authors:  D N Orth; G W Liddle
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

2.  The natural history of treated Cushing's syndrome.

Authors:  R B Welbourn; D A Montgomery; T L Kennedy
Journal:  Br J Surg       Date:  1971-01       Impact factor: 6.939

3.  A survey of results with transsphenoidal surgery in Cushing's disease.

Authors:  W Burch
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

4.  [Results of surgical treatment of 111 cases of adrenocortical hyperfunction (an analysis)].

Authors:  A Kasperlik-Załuska; W Hartwig; J Nielubowicz; W Rudowski; B Migdalska; M Kobuszewska-Faryna; J Załuska
Journal:  Endokrynol Pol       Date:  1978 Jul-Aug       Impact factor: 1.582

5.  Cushing's syndrome. Analysis of 18 cases.

Authors:  G Skalkeas; J G Gogas; M N Sechas; A Kostakis; F Pavlatos
Journal:  Am J Surg       Date:  1982-03       Impact factor: 2.565

6.  Cushing's disease--18 years' experience.

Authors:  R C Urbanic; J M George
Journal:  Medicine (Baltimore)       Date:  1981-01       Impact factor: 1.889

7.  Cushing's syndrome: diagnostic criteria.

Authors:  E J Ross; P Marshall-Jones; M Friedman
Journal:  Q J Med       Date:  1966-04

8.  Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.

Authors:  M N Starkman; D E Schteingart
Journal:  Arch Intern Med       Date:  1981-02

9.  Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment.

Authors:  A Tomita; S Suzuki; I Hara; Y Oiso; S Mizuno; H Yogo; A Kuwayama; N Kageyama
Journal:  Endocrinol Jpn       Date:  1981-04

10.  Surgical experience with Cushing's disease.

Authors:  H W Scott; G W Liddle; J L Mulherin; T J Mckenna; S L Stroup; R K Rhamy
Journal:  Ann Surg       Date:  1977-05       Impact factor: 12.969

View more
  4 in total

1.  Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients.

Authors:  M Iacobone; F Mantero; S M Basso; F Lumachi; G Favia
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

2.  Severe respiratory failure secondary to Cushing's myopathy.

Authors:  C Blanco; M Marazuela; J Flores; J Alvarez
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

3.  Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center.

Authors:  Anand Kumar Mishra; Amit Agarwal; Sushil Gupta; G Agarwal; A K Verma; S K Mishra
Journal:  World J Surg       Date:  2007-05-30       Impact factor: 3.352

Review 4.  Glucocorticoid excess and COVID-19 disease.

Authors:  Valentina Guarnotta; Rosario Ferrigno; Marianna Martino; Mattia Barbot; Andrea M Isidori; Carla Scaroni; Angelo Ferrante; Giorgio Arnaldi; Rosario Pivonello; Carla Giordano
Journal:  Rev Endocr Metab Disord       Date:  2020-10-06       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.